Projects per year
Fingerprint
Dive into the research topics where Carol Lutz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 4 Finished
-
Computational and Experimental Analysis of RNA structures in mRNA polyadenylation
Lutz, C. & Tian, B.
National Human Genome Research Institute
7/22/09 → 6/30/12
Project: Research project
-
Mechanisms of MeCP2 gene expression regulation
Eunice Kennedy Shriver National Institute of Child Health and Human Development
3/15/07 → 2/28/10
Project: Research project
-
3' end formation of human type I and II collagen mRNAs
National Institute of Arthritis and Musculoskeletal and Skin Diseases
1/15/05 → 11/30/08
Project: Research project
-
Mechanisms of post-transcriptional regulation of MeCP2
Eunice Kennedy Shriver National Institute of Child Health and Human Development
7/1/02 → 6/30/05
Project: Research project
-
PACER lncRNA regulates COX-2 expression in lung cancer cells
Desind, S. Z., Iacona, J. R., Yu, C. Y., Mitrofanova, A. & Lutz, C. S., 2022, In: Oncotarget. 13, 1, p. 291-306 16 p.Research output: Contribution to journal › Article › peer-review
Open Access -
MiR-708 Negatively Regulates TNF α /IL-1 β Signaling by Suppressing NF- κ B and Arachidonic Acid Pathways
Monteleone, N. J. & Lutz, C. S., 2021, In: Mediators of Inflammation. 2021, 5595520.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Molecular recognition of structurally disordered Pro/Ala-rich sequences (PAS) by antibodies involves an Ala residue at the hot spot of the epitope
Schilz, J., Binder, U., Friedrich, L., Gebauer, M., Lutz, C., Schlapschy, M., Schiefner, A. & Skerra, A., Sep 3 2021, In: Journal of molecular biology. 433, 18, 167113.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations -
miR-708-5p enhances erlotinib/paclitaxel efficacy and overcomes chemoresistance in lung cancer cells
Monteleone, N. J. & Lutz, C. S., Dec 22 2020, In: Oncotarget. 11, 51, p. 4699-4721 23 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations -
miR-708-5p targets oncogenic prostaglandin E2 production to suppress a pro-tumorigenic phenotype in lung cancer cells
Monteleone, N. J. & Lutz, C. S., Jun 30 2020, In: Oncotarget. 11, 26, p. 2464-2483 20 p.Research output: Contribution to journal › Article › peer-review
Open Access11 Scopus citations